Mohammad Riazi Esfahani

picture of Mohammad Riazi Esfahani

HS Clinical Professor, Ophthalmology
School of Medicine

M.D., Tehran University of Medical Sciences - Tehran, Iran, 1990

Phone: For Appointments: (949) 824-2020 Academic Office:(949) 824-7944

University of California, Irvine
850 Health Sciences Rd.
Mail Code: 4375
Irvine, CA 92697
Research Interests
Retinopathy of Prematurity, Childhood Retinal Detachment, Age-Related Macular Degeneration, Diabetic Retinopathy
111. Mohtashami Z, Akbari Javar H, Rafiee Tehrani M, Riazi Esfahani M, Roohipoor R, Aghajanpour L, Dorkoosh FA 5. Fabrication, Optimization, and In Vitro and In Vivo Characterization of Intra-vitreal Implant of Budesonide Generally Made of PHBV. AAPS PharmSciTech.2020 Nov. 21, 314.

110. Jalili J, Hejazi S, Mohammad Riazi-Esfahani M, Eliasi A, Ebrahimi M, Seydi M, Aghsaei Fard M, Ahmadian A. Erratum: Retinal image mosaicking using scale-invariant feature transformation feature descriptors and Voronoi diagram.SPIE Digital Library. 2020 Jul

109. Khojasteh H, Riazi H, Khalili E, Faghihi H, Ghassemi F, Bazvand F, Mahmoudzadeh R, Salabati M, Mirghorbani M, Riazi Esfahani M. Multifocal Electroretinogram in Diabetic Macular Edema and its Correlation with Different Optical Coherence Tomography Features. Int Ophthalmol. 2020 Mar; 40: 571-581.

108. Ebrahimiadib N, Lashay A, Riazi H, Jamali S, Khodabandeh A, Zarei M, Roohipoor R, Khojasteh H, Bazvand F, Ojani M, Shahabinejad M, Yaseri M, Mojtahedi M, Davoudi S, Riazi Esfahani M. Intravitreal Ziv-Aflibercept in Patients with Diabetic Macular Edema Refractory to Intravitreal Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2020 Mar; Vol 51: 3.

107. Salimiaghdam N, Riazi-Esfahani M, Fukuhara P, Schneider K, Kenney Cristina. Age-related Macular Degeneration (AMD): A Review on its Epidemiology and Risk Factors. The Open Ophthalmology Journal, 2019; Vol 13: 90-99.

106. Ghiam BK, Israelsen P, Wang A, Grob S, Riazi Esfahani M. Klebsiella pneumoniae endogenous endophthalmitis presenting as orbital cellulitis. GMS Ophthalmol Cases. 2019 Aug 20; 9:Doc30. doi: 10.3205/oc000119. eCollection 2019

105. Riazi Esfahani M, Kenney MC, Kuppermann BD. Mitochondrial Repair in Dry Age-Related Macular Degeneration. Retinal Physician. 2019 Apr; 48-54.

104. Karkhaneh R, Ahmadraji A, Riazi Esfahani M, et al. The Accuracy of Digital Imaging in Diagnosis of Retinopathy of Prematurity in Iran: A Pilot Study. Journal of Ophthalmic Vis Res. 2019; 14 (1): 38-41.

103. Azadi P, Khodabande A, Riazi Esfahani M, Ghassemi F, Aliabadi N. Bilateral Choroidal Osteoma associated with Langerhans Cell Histiocytosis, a Coincidense? Journal of Current Ophthalmology. 2019 Mar; 31(1): 109–112.

102. Roohipoor R, Karkhaneh R, Riazi Esfahani M, et al. Comparison of Intravitreal Bevacizumab and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity. Ophthalmology Retina. 2018 Sep;2(9):942-948.

101. Karkhaneh R, Torabi H, Khodabandeh A, Roohipour R, Riazi Esfahani M, Efficacy of intravitreal bevacizumab for the treatment of zone I type 1 retinopathy of prematurity. J Ophthalmic Vis Res. 2018; 13(1): 29-33.

100. Khalilipoor E, Pourreza H, Zamani KA, Mahmoudi A, Sadeghi AM, Shadravan M, Karkhaneh R, Roohipoor R, Riazi Esfahani M. Retinopathy of prematurity-assist: Novel software for detecting plus disease. Korean J Ophthalmol. 2017 Dec; 31(6): 524–532.

99. Riazi Esfahani M, Kuppermann BD, Kenney MC. The role of Mitochondria in AMD: Current knowledge and future applications. J Ophthalmic Vis Res. 2017 Oct-Dec; 12(4):424-8.

98. Torabi H, Riazi Esfahani M, Tabatabai SA. Endophthalmitis in the tertiary referral center in Iran; Etiology and causative organisms. Hosp Pract Res. 2017 Sep;2(3):79-83.

97. Soleimannejad M, Ebrahimi-Barough S, Soleimani M, Nadri S, Tavangar SM, Tavangar SM, Roohipoor R, Yazdankhan N, Bayat M, Riazi-Esfahani M, Ai J. Fibrin gel as a scaffold for photoreceptor cells differentiation from conjunctiva mesenchymal stem cells in retina tissue engineering. Artif Cells Nanomed Biotechnol. 2017 Jul; 10:1-10.

96. Soleimannejad M, Ebrahimi-Barough S, Nadri S, Riazi-Esfahani M, et al. Retina tissue engineering by conjunctival mesenchymal stem cells encapsulated in fibrin gel: Hypotheses on novel approach to Retinal diseases treatment. Medical Hypotheses. 2017 Apr;101:75-77.

95. Riazi Esfahani M, Riazi Esfahani H, Ahmadraji A et al. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial. Int Ophthalmol. 2017 Mar 27.

94. Estrago Franco F, Tarek M, Riazi Esfahani M, Sapkal A, Piche-Lopez R, Patil A, Sharma A, Falatoonzadeh P, Chwa M, Luczy-Bachman G, Kuppermann B, Kenney C. Effects of benzo (e)pyrene on ROS/RNS and inflammatory cytokines induction in human RPE cells and attenuation by mitochondrial-involved mechanism. J Ophthalmic Vis Res. 2016 Oct-Dec; 11(4):385-93.

93. Roohipoor R, Sharifian E, Ghassemi F, Riazi Esfahan M, et al. Choroidal thickness changes in proliferative diabetic retinopathy treated with panretinal photocoagulation versus panretinal photocoagulation with intravitreal bevacizumab. Retina. 2016 Oct; 36(10):1997-2005.

92. EbrahimiAdib N, Roohipour R, Karkhaneh R, Farahani A, Riazi Esfahani M, et al. Internet-based versus conventional referral system for retinopathy of prematurity screening in Iran. Ophthalmic Epidemiology. 2016 Oct 6; 23(5):292-7.

91. Roohipoor R, Karkhaneh R, Farahani A, Ebrahimiadib N, Mojtahedi B, Fotouhi A, Yaseri M, Khodabande A, Zarei M, Imani M, Taheri A, Riazi Esfahani M, Loewenstein J. Retinopathy of prematurity screening criteria in Iran: new screening guideline. Arch Dis Child Fetal Neonatal Ed. 2016 Jul 12;101(4):288-93.

90. Karkhaneh R, Khodabande A, Riazi Esfahan M, et al. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity. Acta Ophthalmol. 2016 Sep;94(6):e417-20.

89. Karkhaneh R, Ahmadraji A, Riazi Esfahani M, et al. Complement factor H and LOC387715/ARMS2/HTRA1 variant's frequencies and phenotypic associations in neovascular age-related macular degeneration, a pilot study. J Curr Ophthalmol. 2016 March; 8(28): 32-6.

88. Roohipoor R, Karkhaneh R, Riazi Esfahani M, et al. Comparison of refractive error changes in ROP patients treated with diode and green LASER. Ophthalmologica. 2016 26; 235(3):173-8.

87. Beheshtian M, Saeerad S, Babanejad M, Mohseni M, Hashemi H, Eshghabadi A, Hajizadeh F, Akbari MR, Kahrizi K, Riazi Esfahani M, Najmabadi H. Impact of whole exome sequencing among Iranian patients with autosomal recessive RP. Arch Iran Med. 2015 Nov; 18(11):776-85.

86. Riazi Esfahani M, Khademi MR, Mazloumi M, Khodabandeh A, Riazi Esfahani H. Macular surgery using spectral domain OCT. J Ophthalmic Vis Res. 2015; 10 (3):309-15.

85. Mazaheri N, Riazi Esfahani H, Jafarzadehpoor E, Mirzajani A, Talebi H, Aminii A, Mazloumi M, Roohipoor R, Riazi Esfahani M. Multifocal ERG in diabetic macular edema; Correlation with visual acuity and OCT. J Ophthalmic Vis Res. 2015; 10(2):165-71.

84. Roohipoor R, Riazi Esfahani M, Ebrahimiadib N, et al. Predictive value of pupillary response to mydriatic agents for diagnosis of retinopathy of prematurity. J Ophthalmic Vis Res. 2015 Oct-Dec; 10(4):417-23.

83. Tamaddon L, Mostafavi SA, Karkhaneh R, Riazi Esfahani M, Rafiee-Tehrani M. Thermo-analytical characterization of clindamycin loaded implants prepared by hot melt extrusion. Adv Biomed Res. 2015; 27(4):147.

82. Riazi Esfahani M, Riazi Esfahani H, Mahmoudi A, Johari MK, Hemati K. Focal choroidal excavation in best vitteliform macular dystrophy: A case report. Journal of Clinical and Diagnostic Research. 2015 May; 9(5):ND01-ND02.

81. Tabatabaei SA, Soleimani M, Mansouri MR, Ebrahimi M, Abdi P, Riazi Esfahani M. Exogenous endophthalmitis due to ellicit drug injection in an IV drug abuser. Open J Ophthalmology. 2015; 5:155-7.

80. Varshochian R, Riazi Esfahani M, Jeddi-Tehrani M, Mahmoudi AR, Aghazadeh S. et al. Albuminated PLGA nanoparticles containing Bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A. 2015 Oct;103(10):3148-56.

79. Tamaddon L, Mostafavi SA, Karkhaneh R, Riazi Esfahani M. Et al. Design and development of intraocular polymeric implant system for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis. Adv Biomed Res. 2015 Jan 30;4:32.
Professional Societies:

2017 Association for Research in Vision and Ophthalmology
2013- Present American Society of Retinal Specialists (ASRS)
2008- 2009 European Vitreoretinal Society (EVRS)
2003- Present American Academy of Ophthalmology (AAO)
2003-2004 Association for Research in Vision and Ophthalmology
1993-present Iranian Society of Ophthalmology (IrSO)
1990-Present Iranian Medical Council Organization
Last updated